Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors

被引:0
|
作者
Michael W. Jann
Kara L. Shirley
Gary W. Small
机构
[1] Mercer University,Department of Clinical and Administrative Sciences, Southern School of Pharmacy
[2] Albany College of Pharmacy,Department of Pharmacy Practice
[3] University of California,Department of Psychiatry and Biobehavioral Sciences, Center on Aging and Alzheimer’s Disease Research Center
[4] Mercer University,Southern School of Pharmacy
来源
Clinical Pharmacokinetics | 2002年 / 41卷
关键词
Cholinesterase; Fluvoxamine; Cholinesterase Inhibitor; Rivastigmine; Tacrine;
D O I
暂无
中图分类号
学科分类号
摘要
Cholinesterase inhibitors are the ‘first-line’ agents in the treatment of Alzheimer’s disease. This article presents the latest information on their pharmacokinetic properties and pharmacodynamic activity.
引用
收藏
页码:719 / 739
页数:20
相关论文
共 50 条
  • [31] Clinical Pharmacokinetics and Pharmacodynamics of Cediranib
    Weifeng Tang
    Alex McCormick
    Jianguo Li
    Eric Masson
    Clinical Pharmacokinetics, 2017, 56 : 689 - 702
  • [32] Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide
    Vibeke Hatorp
    Clinical Pharmacokinetics, 2002, 41 : 471 - 483
  • [33] Clinical Pharmacokinetics and Pharmacodynamics of Torasemide
    Heinrich Knauf
    Ernst Mutschler
    Clinical Pharmacokinetics, 1998, 34 : 1 - 24
  • [34] Clinical Pharmacokinetics and Pharmacodynamics of Tigecycline
    April Barbour
    Stephan Schmidt
    Benjamin Ma
    Lars Schiefelbein
    Kenneth H. Rand
    Olaf Burkhardt
    Hartmut Derendorf
    Clinical Pharmacokinetics, 2009, 48 : 575 - 584
  • [35] CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF CARVEDILOL
    MORGAN, T
    CLINICAL PHARMACOKINETICS, 1994, 26 (05) : 335 - 346
  • [36] Clinical Pharmacokinetics and Pharmacodynamics of Panobinostat
    Van Veggel, Mathilde
    Westerman, Elsbeth
    Hamberg, Paul
    CLINICAL PHARMACOKINETICS, 2018, 57 (01) : 21 - 29
  • [37] Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib
    Richat Abbas
    Poe-Hirr Hsyu
    Clinical Pharmacokinetics, 2016, 55 : 1191 - 1204
  • [38] Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib
    Campagne, Olivia
    Yeo, Kee Kiat
    Fangusaro, Jason
    Stewart, Clinton F.
    CLINICAL PHARMACOKINETICS, 2021, 60 (03) : 283 - 303
  • [39] Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat
    Kamel, Bishoy
    Graham, Garry G.
    Williams, Kenneth M.
    Pile, Kevin D.
    Day, Richard O.
    CLINICAL PHARMACOKINETICS, 2017, 56 (05) : 459 - 475
  • [40] Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole
    Matthew W. McCarthy
    Brad Moriyama
    Ruta Petraitiene
    Thomas J. Walsh
    Vidmantas Petraitis
    Clinical Pharmacokinetics, 2018, 57 : 1483 - 1491